CLK3 regulates tumor angiogenesis by modulating HIF1α ubiquitination
Jing Shen, Wen Zhang, Zhiqiang Chu, Lei Zhu, Yan Feng, Xuling Sun · 2026
Read CLK3 regulates tumor angiogenesis by modulating HIF1α ubiquitination by Jing Shen, Wen Zhang, Zhiqiang Chu, Lei Zhu, Yan Feng, Xuling Sun (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13518250.txt.
Description
Jing Shen and five colleagues pin a splicing kinase as a guardian of tumours' oxygen sensor in a 2026 study. Tumours grow blood vessels under the command of HIF1α, a protein that senses low oxygen and normally gets shredded when oxygen returns. In colorectal cancer data, the kinase CLK3 rose alongside vessel-growth programmes. Lab and animal tests agreed: extra CLK3 boosted tumour vessel growth, and deleting it stalled the process.
The mechanism is protective custody. CLK3 binds HIF1α directly and blocks the tagging that sends it to the shredder, while also adding its own phosphate marks to the protein. Without HIF1α, CLK3's vessel promotion collapsed, proving the partnership essential. Shen's team proposes CLK3 as both a drug target and a marker for colorectal cancers leaning on this pathway, in a field hungry for options after standard vessel blockers fail.
Catalog record
| CREATOR | Jing Shen, Wen Zhang, Zhiqiang Chu, Lei Zhu, Yan Feng, Xuling Sun |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |